Melatonine Pharma Nord (Melatonin)

Melatonin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, signalling that it is nighttime. This interaction shifts the circadian clock, lowers alertness, and facilitates the onset of sleep, helping the body align its internal rhythm with external darkness.

The appropriate dose is individualized and set by a prescriber based on the patient’s age, the specific sleep condition being treated, and any concurrent medications. Clinicians may start with a low dose and adjust as needed to achieve the desired sleep benefit.

Safety data for melatonin use in pregnancy and lactation are limited, and the product does not have an established pregnancy category. Healthcare providers usually recommend avoiding melatonin during pregnancy or while breastfeeding unless the potential benefit outweighs the uncertain risk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Melatonin differs from traditional sedative hypnotics such as benzodiazepines or Z‑drugs because it works by resetting the circadian clock rather than directly depressing the central nervous system. It generally has a lower risk of dependence and fewer cognitive side effects, but its efficacy is most pronounced for circadian‑related sleep disturbances.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and light, and ensure the container is tightly closed after each use to maintain product stability.

Melatonine Pharma Nord is taken orally, usually with a glass of water. It is typically taken 30‑60 minutes before the desired bedtime, but the exact timing should follow the prescribing clinician’s instructions.

While rare, serious adverse reactions can include allergic responses such as rash, swelling, or difficulty breathing, as well as mood changes like depression or suicidal thoughts. Any signs of severe reaction should prompt immediate medical attention.

Melatonin should be avoided in individuals with known hypersensitivity to melatonin, those taking monoamine oxidase inhibitors without medical supervision, and patients with uncontrolled depression or severe psychiatric disorders unless a physician determines it is appropriate.